The U.S. FDA has approved AbbVie's VYALEV, a continuous levodopa infusion for advanced Parkinson's disease. Studies show improved motor symptom management compared to oral medication.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
The U.S. FDA has approved AbbVie's VYALEV, a continuous levodopa infusion for advanced Parkinson's disease. Studies show improved motor symptom management compared to oral medication.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.